Community acquired paediatric pneumonia; experience from a pneumococcal vaccine- naive population

Sanath Thushara Kudagammana1, Ruchira Ruwanthika Karunaratne1, Thilini Surenika Munasinghe1

  • 1Department of Paediatrics, Faculty of Medicine, University of Peradeniya, Peradeniya, 20400 Sri Lanka.

Pneumonia (Nathan Qld.)
|August 29, 2020
PubMed

Insights

Childhood community-acquired pneumonia caused significant illness in children but no deaths. Many required second-line antibiotics, suggesting potential antibiotic resistance in Sri Lanka.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Childhood pneumonia remains a major cause of mortality globally, particularly in South-East Asia and Africa.
  • Pneumonia accounted for 16% of global under-five deaths in 2015, with nearly one million fatalities.
  • Sri Lanka reported 21,000 pneumonia cases in 2006, with 40% affecting children under four.

Purpose of the Study:

  • To analyze the clinical characteristics, management, and outcomes of community-acquired pneumonia in children.
  • To assess the morbidity and mortality associated with pediatric pneumonia in the studied population.

Main Methods:

  • A retrospective study was conducted on children aged 1 month to 14 years admitted with community-acquired pneumonia.
  • Data were collected from patient records between March 2016 and July 2017.

Main Results:

  • Bronchopneumonia was diagnosed in 48% of the 127 patients.
  • Two-thirds of patients required second-line intravenous antibiotics.
  • 51% of patients needed high-dependency unit care with supplemental oxygen; no mortality was observed.

Conclusions:

  • Community-acquired pediatric pneumonia is associated with significant morbidity but not mortality in this population.
  • The high need for second-line antibiotics suggests potential antibiotic resistance.
  • Implementing a national antibiotic policy is recommended to address this issue.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
583
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
675
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
3.0K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
637